NO20023345L - Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO20023345L
NO20023345L NO20023345A NO20023345A NO20023345L NO 20023345 L NO20023345 L NO 20023345L NO 20023345 A NO20023345 A NO 20023345A NO 20023345 A NO20023345 A NO 20023345A NO 20023345 L NO20023345 L NO 20023345L
Authority
NO
Norway
Prior art keywords
pyrido
preparation
pharmaceutical compositions
compositions containing
pyrazine compounds
Prior art date
Application number
NO20023345A
Other languages
English (en)
Other versions
NO322966B1 (no
NO20023345D0 (no
Inventor
Solo Goldstein
Guillaume Poissonnet
Jean-Gilles Parmentier
Pierre Lestage
Brian Lockhart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20023345D0 publication Critical patent/NO20023345D0/no
Publication of NO20023345L publication Critical patent/NO20023345L/no
Publication of NO322966B1 publication Critical patent/NO322966B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20023345A 2001-07-12 2002-07-11 Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO322966B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20023345D0 NO20023345D0 (no) 2002-07-11
NO20023345L true NO20023345L (no) 2003-01-13
NO322966B1 NO322966B1 (no) 2006-12-18

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023345A NO322966B1 (no) 2001-07-12 2002-07-11 Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (25)

Country Link
US (1) US6992085B2 (no)
EP (1) EP1275647B1 (no)
JP (1) JP3950018B2 (no)
KR (1) KR100485020B1 (no)
CN (1) CN1197863C (no)
AR (1) AR036166A1 (no)
AT (1) ATE254124T1 (no)
AU (1) AU2002300094B2 (no)
BR (1) BR0202681A (no)
CA (1) CA2394027C (no)
DE (1) DE60200089T2 (no)
DK (1) DK1275647T3 (no)
EA (1) EA005160B1 (no)
ES (1) ES2210219T3 (no)
FR (1) FR2827288B1 (no)
HK (1) HK1050682A1 (no)
HU (1) HUP0202282A3 (no)
MX (1) MXPA02006699A (no)
NO (1) NO322966B1 (no)
NZ (1) NZ520120A (no)
PL (1) PL355034A1 (no)
PT (1) PT1275647E (no)
SI (1) SI1275647T1 (no)
TR (1) TR200302001T4 (no)
ZA (1) ZA200205596B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004089410A1 (ja) * 2003-04-03 2006-07-06 協和醗酵工業株式会社 神経因性疼痛の予防及び／または治療剤
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA06015267A (es) * 2004-06-22 2007-03-15 Pfizer Prod Inc Antagonistas diazabiciclicos del receptor histamina-3.
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
ES2375929T3 (es) * 2005-07-04 2012-03-07 High Point Pharmaceuticals, Llc Antagonistas del receptor histamina h3.
CA2646023A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
EP3744721A4 (en) 2018-01-26 2021-11-10 Shionogi & Co., Ltd CONDENSED CYCLIC COMPOUND WITH ANTAGONISM TO DOPAMINE D3 RECEPTOR

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
AU5291793A (en) * 1992-09-24 1994-04-12 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
DE60031686T2 (de) * 1999-07-19 2007-08-30 Merck Frosst Canada Ltd., Kirkland Pyrazinone, diese verbindungen enthaltende zusammenstellungen

Also Published As

Publication number Publication date
BR0202681A (pt) 2003-05-06
CN1197863C (zh) 2005-04-20
PT1275647E (pt) 2004-03-31
EP1275647A1 (fr) 2003-01-15
FR2827288B1 (fr) 2003-10-31
CA2394027A1 (fr) 2003-01-12
ZA200205596B (en) 2003-03-27
SI1275647T1 (en) 2004-02-29
HUP0202282A2 (hu) 2003-03-28
NO322966B1 (no) 2006-12-18
US20030195216A1 (en) 2003-10-16
HU0202282D0 (no) 2002-09-28
JP2003064081A (ja) 2003-03-05
HK1050682A1 (en) 2003-07-04
US6992085B2 (en) 2006-01-31
DK1275647T3 (da) 2004-03-15
ATE254124T1 (de) 2003-11-15
TR200302001T4 (tr) 2004-01-21
FR2827288A1 (fr) 2003-01-17
PL355034A1 (en) 2003-01-13
ES2210219T3 (es) 2004-07-01
NZ520120A (en) 2004-03-26
NO20023345D0 (no) 2002-07-11
EP1275647B1 (fr) 2003-11-12
MXPA02006699A (es) 2005-08-16
AR036166A1 (es) 2004-08-18
KR100485020B1 (ko) 2005-04-25
AU2002300094B2 (en) 2007-06-14
KR20030007159A (ko) 2003-01-23
DE60200089T2 (de) 2004-09-09
CA2394027C (fr) 2008-01-08
EA005160B1 (ru) 2004-12-30
HUP0202282A3 (en) 2003-11-28
JP3950018B2 (ja) 2007-07-25
CN1397557A (zh) 2003-02-19
DE60200089D1 (de) 2003-12-18
EA200200663A1 (ru) 2003-02-27

Similar Documents

Publication Publication Date Title
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
NO20022285L (no) Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
HUP0300080A3 (en) Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
NO20003764D0 (no) Nye <beta>-karbolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20023345L (no) Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010522L (no) Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20026154D0 (no) Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20014945L (no) Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
ZA200406844B (en) Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
NO20021330D0 (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20031643L (no) Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021198D0 (no) Nye isoindoloindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
NO20016069D0 (no) Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20023409D0 (no) Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
WO2001049689A3 (en) NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
NO20023389D0 (no) Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20013710D0 (no) Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20035215L (no) Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20011862L (no) Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021806D0 (no) Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20052330D0 (no) Nye substituerte [1,4]benzodioksino[2,3]isoindolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20020262D0 (no) Nye cykloheptenforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010801D0 (no) Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20022794L (no) Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees